KIDS Orthopediatrics Corp
Price (delayed)
$28.74
Market cap
$695.92M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.09
Enterprise value
$678.65M
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such it has developed the most comprehensive product offering to the pediatric
Highlights
KIDS's debt is down by 44% since the previous quarter and by 2.6% year-on-year
The gross profit has increased by 30% year-on-year and by 9% since the previous quarter
The quick ratio has contracted by 37% YoY and by 2.1% from the previous quarter
The net income has contracted by 14% from the previous quarter
Key stats
What are the main financial stats of KIDS
Market
Valuations
Earnings
Shares outstanding
24.21M
Market cap
$695.92M
Enterprise value
$678.65M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.84
Price to sales (P/S)
3.8
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.88
Revenue
$175.07M
EBIT
-$26.41M
EBITDA
-$7.15M
Free cash flow
-$48.45M
Per share
Balance sheet
Liquidity
EPS
-$1.09
Free cash flow per share
-$2.09
Book value per share
$15.58
Revenue per share
$7.56
TBVPS
$10.96
Total assets
$430.76M
Total liabilities
$59.47M
Debt
$13.61M
Equity
$371.29M
Working capital
$154.21M
Debt to equity
0.04
Current ratio
4.9
Quick ratio
1.84
Net debt/EBITDA
2.42
Margins
Efficiency
Dividend
EBITDA margin
-4.1%
Gross margin
74.6%
Net margin
-14.3%
Operating margin
-16%
Return on assets
-5.8%
Return on equity
-6.7%
Return on invested capital
-12.4%
Return on capital employed
-6.8%
Return on sales
-15.1%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
KIDS stock price
How has the Orthopediatrics stock price performed over time
Intraday
-1.61%
1 week
-10.97%
1 month
0.88%
1 year
-13.15%
YTD
-11.6%
QTD
-0.07%
Financial performance
How have Orthopediatrics's revenue and profit performed over time
Revenue
$175.07M
Gross profit
$130.64M
Operating income
-$27.96M
Net income
-$25.12M
Gross margin
74.6%
Net margin
-14.3%
The gross profit has increased by 30% year-on-year and by 9% since the previous quarter
The revenue rose by 28% year-on-year and by 8% since the previous quarter
KIDS's operating margin is up by 26% year-on-year and by 7% since the previous quarter
The net income has contracted by 14% from the previous quarter
Growth
What is Orthopediatrics's growth rate over time
Valuation
What is Orthopediatrics stock price valuation
P/E
N/A
P/B
1.84
P/S
3.8
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.88
The EPS has declined by 14% since the previous quarter
The price to book (P/B) is 49% less than the 5-year quarterly average of 3.7
The equity has declined by 2.4% year-on-year
KIDS's price to sales (P/S) is 57% lower than its 5-year quarterly average of 8.9 and 14% lower than its last 4 quarters average of 4.5
The revenue rose by 28% year-on-year and by 8% since the previous quarter
Efficiency
How efficient is Orthopediatrics business performance
The return on assets has declined by 16% since the previous quarter
KIDS's ROIC is down by 15% from the previous quarter
Orthopediatrics's ROE has decreased by 14% from the previous quarter
The return on sales has declined by 3.4% since the previous quarter
Dividends
What is KIDS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for KIDS.
Financial health
How did Orthopediatrics financials performed over time
The quick ratio has contracted by 37% YoY and by 2.1% from the previous quarter
KIDS's total liabilities is down by 11% since the previous quarter but it is up by 9% year-on-year
KIDS's debt is 96% smaller than its equity
KIDS's debt is down by 44% since the previous quarter and by 2.6% year-on-year
The debt to equity has contracted by 43% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.